GSA Capital Partners’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Buy |
186,062
+165,431
| +802% | +$746K | 0.06% | 572 |
|
|
2025
Q1 | $91K | Buy |
+20,631
| New | +$91K | 0.01% | 1513 |
|
|
2023
Q4 | – | Sell |
-137,299
| Closed | -$748K | – | 1996 |
|
|
2023
Q3 | $748K | Buy |
137,299
+92,765
| +208% | +$505K | 0.06% | 554 |
|
|
2023
Q2 | $302K | Sell |
44,534
-116,975
| -72% | -$793K | 0.03% | 1048 |
|
|
2023
Q1 | $809K | Buy |
161,509
+62,349
| +63% | +$312K | 0.08% | 433 |
|
|
2022
Q4 | $484K | Buy |
+99,160
| New | +$484K | 0.06% | 620 |
|
|
2022
Q1 | – | Sell |
-69,311
| Closed | -$1.12M | – | 1904 |
|
|
2021
Q4 | $1.12M | Buy |
+69,311
| New | +$1.12M | 0.14% | 155 |
|
|
2018
Q4 | – | Sell |
-10,000
| Closed | -$266K | – | 1792 |
|
|
2018
Q3 | $266K | Buy |
+10,000
| New | +$266K | 0.01% | 1377 |
|